AAAAAA
Results:
1-18
|
Results: 18
Authors:
Gianni, L
Panzini, I
Tassinari, D
Mianulli, AM
Desiderio, F
Ravaioli, A
Citation: L. Gianni et al., Meta-analyses of randomized trials of adjuvant chemotherapy in gastric cancer, ANN ONCOL, 12(8), 2001, pp. 1179-1180
Authors:
Tassinari, D
Sartori, S
Ravaioli, A
Citation: D. Tassinari et al., Staging of breast cancer. Is the evidence so evident?, ANN ONCOL, 12(11), 2001, pp. 1653-1653
Authors:
Ravaioli, A
Tassinari, D
Panzini, I
Milandri, C
Amadori, D
Citation: A. Ravaioli et al., Staging of breast cancer: It is time to break with tradition and initiate the evidence-based-medicine age, J CL ONCOL, 19(4), 2001, pp. 1234-1234
Authors:
Bagli, L
Dittadi, R
Zancan, M
Panzini, I
Monti, F
Ravaioli, A
Citation: L. Bagli et al., HER-2/neu serum levels and menopausal status, INT J B MAR, 16(1), 2001, pp. 69-70
Authors:
Sobrero, A
Guglielmi, A
Cirillo, M
Recaldin, E
Frassineti, GL
Aschele, C
Ravaioli, A
Testore, P
Caroti, C
Gallo, L
Pessi, MA
Cortesi, E
Turci, D
Grossi, F
Labianca, R
Citation: A. Sobrero et al., 5-fluorouracil modulated by leucovorin, methotrexate and mitomycin: highlyeffective, low cost chemotherapy for advanced colorectal cancer, BR J CANC, 84(8), 2001, pp. 1023-1028
Authors:
Tassinari, D
Arcangeli, V
Panzini, I
Sartori, S
Gianni, L
Ravaioli, A
Citation: D. Tassinari et al., Can mitomycin C represent a valid partner for 5-fluorouracil in second-line chemotherapy of colorectal cancer?, ANN ONCOL, 11(8), 2000, pp. 1071-1071
Authors:
Ravaioli, A
Tassinari, D
Citation: A. Ravaioli et D. Tassinari, Staging of breast cancer: recommended standards, ANN ONCOL, 11, 2000, pp. 3-6
Authors:
Sobrero, A
Zaniboni, A
Frassineti, GL
Aschele, C
Guglielmi, A
Giuliani, R
Ravaioli, A
Lanfranco, C
Caroti, C
Arnoldi, E
Barni, S
Gallo, L
Pessi, MA
Turci, D
Cortesi, E
Grossi, F
Frontini, L
Piazza, E
Bruzzi, P
Labianca, R
Citation: A. Sobrero et al., Schedule specific biochemical modulation of 5-fluorouracil in advanced colorectal cancer: A randomized study, ANN ONCOL, 11(11), 2000, pp. 1413-1420
Authors:
Pasquini, E
Rinaldi, P
Nicolini, M
Papi, M
Fabbri, P
Bernardi, L
Ravaioli, A
Citation: E. Pasquini et al., Breast involvement in immunolymphoproliferative disorders: Report of two cases of multiple myeloma of the breast, ANN ONCOL, 11(10), 2000, pp. 1353-1359
Authors:
Amadori, D
Nanni, O
Marangolo, M
Pacini, P
Ravaioli, A
Rossi, A
Gambi, A
Catalano, G
Perroni, D
Scarpi, E
Giunchi, DC
Tienghi, A
Becciolini, A
Volpi, A
Citation: D. Amadori et al., Disease-free survival advantage of adjuvant cyclophosphamide, methotrexate, and fluorouracil in patients with node-negative, rapidly proliferating breast cancer: A randomized multicenter study, J CL ONCOL, 18(17), 2000, pp. 3125-3134
Authors:
Ravaioli, A
Tassinari, D
Panzini, I
Citation: A. Ravaioli et al., Treatment of colorectal - Role of oxaliplatin, TUMORI, 86(3), 2000, pp. S37-S41
Authors:
Oliverio, G
Canuti, D
Tononi, A
Scarpellini, M
Panzini, I
Galli, I
Ravaioli, A
Citation: G. Oliverio et al., Paclitaxel efficacy and tolerability in second-line treatment of refractory and relapsed ovarian cancer patients, J CHEMOTHER, 11(4), 1999, pp. 301-305
Authors:
Maltoni, M
Nanni, O
Pirovano, M
Scarpi, E
Indelli, M
Martini, C
Monti, M
Arnoldi, E
Piva, L
Ravaioli, A
Cruciani, G
Labianca, R
Amadori, D
Citation: M. Maltoni et al., Successful validation of the palliative prognostic score in terminally illcancer patients, J PAIN SYMP, 17(4), 1999, pp. 240-247
Authors:
Crino, L
Scagliotti, GV
Ricci, S
De Marinis, F
Rinaldi, M
Gridelli, C
Ceribelli, A
Bianco, R
Marangolo, M
Di Costanzo, F
Sassi, M
Barni, S
Ravaioli, A
Adamo, V
Portalone, L
Cruciani, G
Masotti, A
Ferrara, G
Gozzelino, F
Tonato, M
Citation: L. Crino et al., Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non-small-cell lung cancer: A randomized phase III study of the Italian lung cancer project, J CL ONCOL, 17(11), 1999, pp. 3522-3530
Authors:
Tassinari, D
Sartori, S
Panzini, I
Ravaioli, A
Iorio, D
Citation: D. Tassinari et al., Hemolytic-uremic syndrome during therapy with estramustine phosphate for advanced prostatic cancer, ONCOL-BASEL, 56(2), 1999, pp. 112-113
Authors:
Ravaioli, A
Bagli, L
Zucchini, A
Monti, F
Citation: A. Ravaioli et al., Prognosis and prediction of response in breast cancer: the current role ofthe main biological markers, CELL PROLIF, 31(3-4), 1998, pp. 113-126
Authors:
Ravaioli, A
Tassinari, D
Pasini, G
Polselli, A
Papi, M
Fattori, PP
Pasquini, E
Masi, A
Alessandrini, F
Canuti, D
Panzini, I
Drudi, G
Citation: A. Ravaioli et al., Staging of breast cancer: What standards should be used in research and clinical practice?, ANN ONCOL, 9(11), 1998, pp. 1173-1177
Authors:
Ciatto, S
Bonardi, R
Ravaioli, A
Canuti, D
Foglietta, F
Modena, S
Zanconati, F
Cressa, C
Ferrara, P
Marrazzo, A
Citation: S. Ciatto et al., Benign breast surgical biopsies: Are they always justified?, TUMORI, 84(5), 1998, pp. 521-524
Risultati:
1-18
|